Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.


IES Virtual Seminar Abstract Submission

The International Eosinophil Society, Inc. (IES) is now accepting Abstract Submissions for virtual presentation in connection with the IES Virtual Seminar sessions.

Click here to submit an abstract.

The deadline EXTENDED to submit an abstract is 15 June 2021

Notes on preparing your Abstract for submission for the Virtual Seminar Sessions of The International Eosinophil Society, Inc.

General Directions:  For a uniform appearance in the Abstract book, all text should be in Arial 11-point font single-spaced with 1.2” margins at top, bottom and right and left sides.  Text (not including title and authors) should be limited to 500 words maximum.  Use abbreviations sparingly and define ones that are likely to be unfamiliar within the text. 

Title:  Upper case letters, bold, and centered. 

Authors:  Full names, middle initial with period, place of work indicated and attributed with numeric superscripts and full documentation as shown. The name of the author presenting at the meeting must be underlined. The system allows for up to 15 authors to be listed. If you have more then 15 authors please make sure that all are listed on file that is uploaded for them to be used in the final program listing of accpected abstracts.


A) Background: A statement of purpose of the study (preferably one sentence).

B)Methods: A brief statement of the methods used. For abstracts reporting clinical research, a sentence or phrase presenting the most important selection criteria for subjects should be included.

C) Results: A summary of the results presented in sufficient detail with statistical analysis to support the conclusions.

D) Conclusions: A statement of the conclusions reached. It is not satisfactory to state, "the results will be discussed," or "other data will be presented," etc.

Grant Support:  Please include as appropriate.

Corporate Advisory Council

Allakos             Amgen             AstraZeneca             GSK